Wealth Enhancement Trust Services’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Wealth Enhancement Trust Services's RPRX Position: Q3 2026 in Review
Wealth Enhancement Trust Services reduced its Royalty Pharma (RPRX) stake by 72% in Q3 2026, selling an estimated $17.2K and leaving 111 shares worth $6.48K. The position accounts for ﹤0.01% of the portfolio, ranked #621.
Wealth Enhancement Trust Services first reported a position in RPRX in Q4 2025 and has held it in 3 quarters since. The position peaked at $22.6K in Q2 2026. 573 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.
- Wealth Enhancement Trust Services held 111 shares of Royalty Pharma worth $6.48K as of Q3 2026.
- Wealth Enhancement Trust Services sold 292 Royalty Pharma shares in Q3 2026, an estimated $17.2K.
- Royalty Pharma made up ﹤0.01% of Wealth Enhancement Trust Services's portfolio in Q3 2026, its #621 holding.
- Wealth Enhancement Trust Services first reported a position in Royalty Pharma in Q4 2025 and has held it in 3 quarters since.
- Wealth Enhancement Trust Services's Royalty Pharma position peaked at $22.6K in Q2 2026.
- 573 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.
Based on Wealth Enhancement Trust Services's 13F filing for Q3 2026, filed 7 Oct 2026.